As of September 21, 2024, Independence Blue Cross (IBX) and Independence Administrators have expanded the Direct Ship Drug Program to include more than 100 injectable and infusion drugs eligible for coverage under the medical benefit.
In-network providers can order any drug on this program at no cost.
Additions to the program
The following drugs will be added to the program:
-
Bkemv
-
Elfabrio
-
Epysqli
-
Jubbonti
-
Opuviz
-
Pombiliti
-
Pyzchiva
-
Rystiggo
-
Ryzneuta
-
Selarsdi
-
Tyenne
-
Udenyca OBI
-
Uptravi IV
-
Wyost
-
Yesafili
As a reminder, all drugs available through the Direct Ship Drug Program are subject to precertification review, even if they are not published on the precertification list.
Learn more
The updated drug list can be found on our Direct Ship Drug Program webpages: